GGrantIndex
Sort

64,565 grants matching drug discovery

Neuroeconomics of Drug Addiction

$718,400
Michael Platt · Duke University · P30 · FY2010 · DA

Allosteric regulation of lysine degradation as a novel pathophysiological mechanism in glutaric aciduria type 1

$718,385
Sander Michel Houten · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · HD

Chemogenomic Profiling of Plasmodium falciparum Drug Responses and Resistance

$718,381
John Adams · University Of South Florida · R01 · FY2015 · AI

CVD in American Indians Biomarker lab and Arizona Field Center

$718,329
Jason G Umans · Medstar Health Research Institute · R01 · FY2017 · HL

CVD in American Indians Biomarker lab and Arizona Field Center

$718,329
Jason G Umans · Medstar Health Research Institute · R01 · FY2016 · HL

Anti-inflammatory drug target to reduce adverse pregnancy outcomes.

$718,324
Suhas Kallapur · University Of California Los Angeles · R01 · FY2020 · HD

NCI Experimental Therapeutics-Clinical Trials Network with Phase 1 Emphasis

$718,215
Alex A Adjei · Mayo Clinic Rochester · UM1 · FY2016 · CA

QCIS-FF: Quantum Computing & Information Science Faculty Fellow at the University of Washington

$718,146
Eric Klavins · University Of Washington · · FY2020 · CSE

Discovery of Oxaboroles as New Antimalarial Agents

$718,136
Philip Jon Rosenthal · University Of California, San Francisco · R56 · FY2011 · AI

Genomic Background of Blood Pressure Response to Thiazide Diuretic in African Americans

$718,131
Marguerite R Irvin · University Of Alabama At Birmingham · R01 · FY2018 · HL

Determinants, Trajectories, and Consequences of Abnormal Cardiac Mechanics

$718,053
Sanjiv J Shah · Northwestern University At Chicago · R01 · FY2016 · HL

Rapid AST through Metabolic Imaging at Single Cell Level

$718,052
Ji-Xin Cheng · Boston University (Charles River Campus) · R01 · FY2023 · AI

Investigate the role of extracellular vesicles in promoting the progression of pulmonary lymphangioleiomyomatosis

$718,036
Magdalena Karbowniczek · Texas Tech University Health Scis Center · R01 · FY2022 · HL

Structural Basis of Protease-Activated Receptor Function

$718,031
Shaun R. Coughlin · University Of California, San Francisco · R01 · FY2016 · HL

Genetic Analysis of Attention Deficit Hyperactivity Disorder

$717,974
Maximilian Muenke · National Human Genome Research Institute · ZIA · FY2016 · HG

Optimization of novel phenotypic screening hits for treatment of Malaria

$717,556
Margaret A. Phillips · Ut Southwestern Medical Center · R01 · FY2025 · AI

Development of IMPDH-Targeted Drugs against Crytosporidium

$717,483
Lizbeth K. Hedstrom · Brandeis University · U01 · FY2010 · AI

Biocontainment Research support services core

$717,476
Farhang Alem · George Mason University · UC7 · FY2023 · AI

NMR Studies of Retroviral Nucleic Acid Binding Proteins

$717,428
Michael F. Summers · University Of Maryland Baltimore County · R01 · FY2025 · AI

Behavioral Phenotyping Core

$717,378
Leona Gagnon · Jackson Laboratory · P50 · FY2022 · DA

Nuclear Factor-kappaB in Ovarian Cancer

$717,308
Christina Annunziata · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA

Miniaturized Stopped-Flow Reaction Microcalorimeter for Biomedical Applications

$717,088
Richard Kenneth Brown · Cape Bioresearch, Inc. · R44 · FY2019 · GM

Bioassay and Ecology Directed Drug Discovery in Panama

$717,000
Smithsonian Institution · U01 · FY2003 · TW

Microphysiological systems to model vascular malformations

$716,989
Christopher C. W. Hughes · University Of California-Irvine · UH3 · FY2019 · HL

Microphysiological systems to model vascular malformations

$716,989
Christopher C. W. Hughes · University Of California-Irvine · UH3 · FY2021 · HL